High response rates after neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma, REDUCTOR trial. Issue 2 (February 2019)

• Record Type: Journal Article
• Authors: Blankenstein, S.; Rohaan, M.; Klop, M.; Van der Hiel, B.; Van de Wiel, B.; Peeper, D.; Haanen, J.; van Akkooi, A.
• Is Part Of: European journal of surgical oncology. Volume 45:Issue 2(2019)
• Page Start: e6
• Publication Date: 2019-02
• Subjects: Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2018.10.118
• Languages: English
• ISSNs: 0748-7983